SS/Hsd |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
blood HDL cholesterol amount |
male |
180 days
| 6 |
|
76.83 |
mg/dl |
1.93 |
4.73 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0 |
|
11887 |
204 |
SS/Hsd |
cubic root of body weight to nasoanal length ratio |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
body mass |
male |
180 days
| 20 |
|
315.4 |
g/mm x 10000 |
1.87 |
8.36 |
body weighing method |
0.0 |
0 |
|
67893 |
204 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
301.6 |
umol/g |
3.9 |
9.55 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102247 |
2682 |
SS/Hsd |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
urine creatinine amount |
male |
60 days-69 days |
0 |
|
11.5 |
mg/d |
0.4 |
|
urine creatinine analysis |
0.0 |
0 |
|
98443 |
2059 |
SS/Hsd |
plasma total cholesterol level |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
blood cholesterol amount |
male |
180 days
| 20 |
|
171.81 |
mg/dl |
6.95 |
31.08 |
plasma total cholesterol measurement test |
|
0 |
|
11884 |
204 |
SS/Hsd |
calculated plasma low density lipoprotein cholesterol level |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
blood LDL cholesterol amount |
male |
180 days
| 6 |
|
57.92 |
mg/dl |
6.95 |
17.02 |
plasma total cholesterol measurement test |
|
0 |
|
11886 |
204 |
SS/Hsd |
body weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
body mass |
male |
60 days-69 days |
0 |
|
321.0 |
g |
5.0 |
|
body weighing method |
0.0 |
0 |
|
98471 |
2059 |
SS/Hsd |
heart rate |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart pumping trait |
male |
58 days-67 days |
0 |
serial mean |
339.0 |
beats/min |
4.0 |
|
intra-aortic abdominal radiotelemetry |
32400.0 |
0 |
|
98424 |
2059 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
140.6 |
mmol/l |
2.4 |
5.88 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102241 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
141.1 |
mmol/l |
1.8 |
4.41 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102254 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
139.6 |
mmol/l |
1.9 |
4.65 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102243 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
300.3 |
umol/g |
4.7 |
11.51 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102245 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
140.4 |
mmol/l |
1.1 |
2.69 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102256 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
301.4 |
umol/g |
4.2 |
10.29 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102261 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
301.2 |
umol/g |
3.2 |
7.84 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102264 |
2682 |
SS/Hsd |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
serial mean |
123.0 |
mmHg |
3.0 |
|
intra-aortic abdominal radiotelemetry |
32400.0 |
0 |
|
98410 |
2059 |
SS/Hsd |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
serial mean |
136.0 |
mmHg |
2.0 |
|
intra-aortic abdominal radiotelemetry |
32400.0 |
0 |
|
98403 |
2059 |
SS/Hsd |
heart wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
heart mass |
male |
60 days-69 days |
0 |
|
1.13 |
g |
0.02 |
|
digital scale post excision weight measurement |
0.0 |
0 |
|
98464 |
2059 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
140.2 |
mmol/l |
2.1 |
5.14 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102242 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
301.8 |
umol/g |
3.8 |
9.31 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102246 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
301.8 |
umol/g |
3.6 |
8.82 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102262 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
140.7 |
mmol/l |
2.2 |
5.39 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102244 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
140.3 |
mmol/l |
1.3 |
3.18 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102253 |
2682 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
299.4 |
umol/g |
3.8 |
9.31 |
osmometry |
0.0 |
0 |
p osmolality mosm/kg |
102263 |
2682 |
SS/Hsd |
single kidney wet weight |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
kidney mass |
male |
60 days-69 days |
0 |
|
1.46 |
g |
0.02 |
|
digital scale post excision weight measurement |
0.0 |
0 |
|
98457 |
2059 |
SS/Hsd |
plasma triglyceride level |
controlled sodium content diet (0.3 %) then fasting (for 16 hours) |
Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 |
blood triglyceride amount |
male |
180 days
| 20 |
|
1.88 |
mmol/l |
0.09 |
0.4 |
plasma triglyceride analysis |
|
0 |
|
11888 |
204 |
SS/Hsd |
plasma osmolality |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood molecular composition trait |
male |
91 days-119 days |
6 |
|
301.3 |
umol/g |
4.3 |
10.53 |
osmometry |
0.0 |
0 |
|
102248 |
2682 |
SS/Hsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) |
Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. |
blood sodium amount |
male |
91 days-119 days |
6 |
|
138.9 |
mmol/l |
1.2 |
2.94 |
flame atomic emission spectrometry |
0.0 |
0 |
|
102255 |
2682 |
SS/Hsd |
systolic blood pressure |
controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 10 days) |
Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. |
arterial blood pressure trait |
male |
58 days-67 days |
0 |
serial mean |
149.0 |
mmHg |
2.0 |
|
intra-aortic abdominal radiotelemetry |
32400.0 |
0 |
|
98417 |
2059 |